Clinical Trials in Pittsburgh

Showing 1161-1180 of 21,047 trials

A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

NCT03401788

This study is designed to investigate belzutifan as a treatment for VHL disease associated RCC.

VHL - Von Hippel-Lindau SyndromeVHL Gene MutationVHL Syndrome+3 more

Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)50 participantsStarted May 2018

Bethesda, Maryland, United States • Boston, Massachusetts, United States • Ann Arbor, Michigan, United States +8 more locations

RECRUITINGPhase 2< 1 mile

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

NCT02960022

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.

Prostate Cancer

Astellas Pharma Global Development, Inc.900 participantsStarted Dec 2016

Anchorage, Alaska, United States • Tucson, Arizona, United States • Los Angeles, California, United States +238 more locations

A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Find Trials by Condition in Pittsburgh

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Testing the Use of VA Peer Specialists to Prevent Veteran Suicide

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

Micro-UltraSound In Cancer - Active Surveillance